Insight Molecular Diagnostic

Stocks Under $10 Biotech Stocks Healthcare Stocks

$5.90

+0.48 (+8.86%)

As of Jun 30, 10:24 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 7 70%

Hold 3 30%

Sell 0 0%

Price Target

Analyst Price Target +195.1% upside

Low Target $14.05

Average Target $17.41

High Target $26.42

Current Price $5.90

Current
$5.90

Target
$17.41

$14.05 $17.41 avg $26.42

Scenario Analysis

Bear Case

$14.05

138.1%

Low target

Base Case

$17.41

+195.1%

Avg target

Bull Case

$26.42

+347.8%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$8.51

-30.7% from high

52-Week Low

$2.33

+153.2% from low

Target vs 52W High

$17.41

+104.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%